Primecap Management CO Edwards Lifesciences Corp Transaction History

Primecap Management CO

$127 Billion
Q4 2024

A detailed history of Primecap Management CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Primecap Management CO holds 2,043,500 shares of EW stock, worth $146 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,043,500

Previous 1,784,700 14.5%

Holding current value

$146 Million

Previous $118 Million 28.45%

% of portfolio

0.12%

Previous 0.09%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$64.54 - $75.92 $16.7 Million - $19.6 Million	258,800 Added 14.5%	2,043,500 $151 Million
Q3 2024 Nov 08, 2024	SELL	$59.7 - $93.78 $1.57 Million - $2.47 Million	-26,300 Reduced 1.45%	1,784,700 $118 Million
Q2 2024 Aug 09, 2024	SELL	$84.3 - $94.31 $7.59 Million - $8.49 Million	-90,000 Reduced 4.73%	1,811,000 $167 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $2.16 Million - $2.72 Million	-35,000 Reduced 1.81%	1,901,000 $145 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $2.23 Million - $2.54 Million	-30,000 Reduced 1.53%	1,936,000 $160 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $6.17 Million - $7.9 Million	-90,300 Reduced 4.39%	1,966,000 $147 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $5.12 Million - $7.59 Million	-59,200 Reduced 2.8%	2,056,300 $196 Million
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $7.42 Million - $9.34 Million	-72,800 Reduced 3.33%	2,115,500 $249 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $8.95 Million - $11 Million	-84,100 Reduced 3.7%	2,188,300 $283 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $15.8 Million - $18.8 Million	-153,100 Reduced 6.31%	2,272,400 $257 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $8.26 Million - $9.52 Million	105,000 Added 4.52%	2,425,500 $203 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $89 Million - $119 Million	1,547,000 Added 200.0%	2,320,500 $160 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $12.5 Million - $19.3 Million	238,500 Added 44.58%	773,500 $146 Million
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $1.3 Million - $1.66 Million	35,000 Added 7.0%	535,000 $74.6 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $858,266 - $1 Million	-25,400 Reduced 4.83%	500,000 $56.4 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $19.1 Million - $20.4 Million	525,400	525,400 $57.4 Million

Others Institutions Holding EW

# of Institutions

1,383

Shares Held

453M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Edwards Lifesciences Corp Transaction History